Terms: = Ovarian cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18
95 results:
1. CDCA5 promoted cell invasion and migration by activating TGF-β1 pathway in human ovarian cancer cells.
Zhang Q; Zhang R; Li Y; Yang X
J Ovarian Res; 2024 Mar; 17(1):68. PubMed ID: 38539247
[TBL] [Abstract] [Full Text] [Related]
2. TMED3 stabilizes smad2 by counteracting NEDD4-mediated ubiquitination to promote ovarian cancer.
Chen X; Zhang W; Han X; Li X; Xia L; Wu Y; Zhou Y
Mol Carcinog; 2024 May; 63(5):803-816. PubMed ID: 38411267
[TBL] [Abstract] [Full Text] [Related]
3. FBXO28 promotes cell proliferation, migration and invasion via upregulation of the TGF-beta1/smad2/3 signaling pathway in ovarian cancer.
Song G; Sun Z; Chu M; Zhang Z; Chen J; Wang Z; Zhu X
BMC Cancer; 2024 Jan; 24(1):122. PubMed ID: 38267923
[TBL] [Abstract] [Full Text] [Related]
4. Occludin is overexpressed in tubo-ovarian high-grade serous carcinoma compared to mesothelioma and is a marker of tumor progression and chemoresistance.
Dos Santos MV; Holth A; Bischof K; Davidson B
Clin Exp Metastasis; 2024 Feb; 41(1):69-76. PubMed ID: 38141113
[TBL] [Abstract] [Full Text] [Related]
5. Expression and prognostic role of STAT5a across cancer types.
Maninang C; Li J; Li WX
Biosci Rep; 2023 Aug; 43(8):. PubMed ID: 37369132
[TBL] [Abstract] [Full Text] [Related]
6. Tumour-derived exosomal piR-25783 promotes omental metastasis of ovarian carcinoma by inducing the fibroblast to myofibroblast transition.
Li G; Yi X; Du S; Gong L; Wu Q; Cai J; Sun S; Cao Y; Chen L; Xu L; Wang Z
Oncogene; 2023 Feb; 42(6):421-433. PubMed ID: 36482201
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy and Clinical Significance of the Zuogui Pill on Premature ovarian Failure via the GDF-9/smad2 Pathway.
Cen S; Qian X; Wu C; Xu X; Yang X
Nutr Cancer; 2023; 75(2):488-497. PubMed ID: 36194038
[TBL] [Abstract] [Full Text] [Related]
8. The miR-33a-5p/CROT axis mediates ovarian cancer cell behaviors and chemoresistance
Li X; Gao X; Yuan J; Wang F; Xu X; Wang C; Liu H; Guan W; Zhang J; Xu G
Front Endocrinol (Lausanne); 2022; 13():950345. PubMed ID: 36120434
[TBL] [Abstract] [Full Text] [Related]
9. Circ TYMP1 Inhibits Carcinogenesis and Cisplatin Resistance in ovarian cancer by Reducing smad2/3 Phosphorylation via a MicroRNA-182A-3p/TGF1B Axis.
Rao Y; Zhang W; Li D; Li X; Ma Y; Qu P
Contrast Media Mol Imaging; 2022; 2022():1032557. PubMed ID: 36072623
[TBL] [Abstract] [Full Text] [Related]
10. Family with sequence similarity 46 member a confers chemo-resistance to ovarian carcinoma via TGF-β/smad2 signaling.
Liang S; Liu Y; He J; Gao T; Li L; He S
Bioengineered; 2022 Apr; 13(4):10629-10639. PubMed ID: 35465837
[TBL] [Abstract] [Full Text] [Related]
11. KLF8 is activated by TGF-β1 via smad2 and contributes to ovarian cancer progression.
Cherukunnath A; Davargaon RS; Ashraf R; Kamdar U; Srivastava AK; Tripathi PP; Chatterjee N; Kumar S
J Cell Biochem; 2022 May; 123(5):921-934. PubMed ID: 35293014
[TBL] [Abstract] [Full Text] [Related]
12. Silibinin exerts anti-cancer activity on human ovarian cancer cells by increasing apoptosis and inhibiting epithelial-mesenchymal transition (EMT).
Maleki N; Yavari N; Ebrahimi M; Faisal Faiz A; Khosh Ravesh R; Sharbati A; Panji M; Lorian K; Gravand A; Abbasi M; Abazari O; Shafiee Mehr M; Eskandari Y
Gene; 2022 May; 823():146275. PubMed ID: 35189245
[TBL] [Abstract] [Full Text] [Related]
13. Wnt5A and TGFβ1 Converges through YAP1 Activity and Integrin Alpha v Up-Regulation Promoting Epithelial to Mesenchymal Transition in ovarian cancer Cells and Mesothelial Cell Activation.
Dehghani-Ghobadi Z; Sheikh Hasani S; Arefian E; Hossein G
Cells; 2022 Jan; 11(2):. PubMed ID: 35053353
[TBL] [Abstract] [Full Text] [Related]
14. Validation of Anticorrelated TGFβ Signaling and Alternative End-Joining DNA Repair Signatures that Predict Response to Genotoxic cancer Therapy.
Guix I; Liu Q; Pujana MA; Ha P; Piulats J; Linares I; Guedea F; Mao JH; Lazar A; Chapman J; Yom SS; Ashworth A; Barcellos-Hoff MH
Clin Cancer Res; 2022 Apr; 28(7):1372-1382. PubMed ID: 35022323
[TBL] [Abstract] [Full Text] [Related]
15. [MUC4 Silencing Inhibits TGF-β1-induced Epithelial-mesenchymal Transition VIA the ERK1/2 Pathway in Human Airway Epithelial NCI-H292 Cells].
Kim YD; Choi YS; Na HG; Song SY; Bae CH
Mol Biol (Mosk); 2021; 55(4):617-625. PubMed ID: 34432779
[TBL] [Abstract] [Full Text] [Related]
16. LncRNA PVT1 promotes the progression of ovarian cancer by activating TGF-β pathway via miR-148a-3p/AGO1 axis.
Wu Y; Gu W; Han X; Jin Z
J Cell Mol Med; 2021 Sep; 25(17):8229-8243. PubMed ID: 34288373
[TBL] [Abstract] [Full Text] [Related]
17. SCRIB Is Involved in the Progression of ovarian Carcinomas in Association with the Factors Linked to Epithelial-to-Mesenchymal Transition and Predicts Shorter Survival of Diagnosed Patients.
Hussein UK; Ahmed AG; Choi WK; Kim KM; Park SH; Park HS; Noh SJ; Lee H; Chung MJ; Moon WS; Kang MJ; Cho DH; Jang KY
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33803371
[TBL] [Abstract] [Full Text] [Related]
18. Role of TSC1 in physiology and diseases.
Mallela K; Kumar A
Mol Cell Biochem; 2021 Jun; 476(6):2269-2282. PubMed ID: 33575875
[TBL] [Abstract] [Full Text] [Related]
19. KRT7 promotes epithelial‑mesenchymal transition in ovarian cancer via the TGF‑β/smad2/3 signaling pathway.
An Q; Liu T; Wang MY; Yang YJ; Zhang ZD; Liu ZJ; Yang B
Oncol Rep; 2021 Feb; 45(2):481-492. PubMed ID: 33416175
[TBL] [Abstract] [Full Text] [Related]
20. The Overexpression of Keratin 23 Promotes Migration of ovarian cancer via Epithelial-Mesenchymal Transition.
Ren M; Gao Y; Chen Q; Zhao H; Zhao X; Yue W
Biomed Res Int; 2020; 2020():8218735. PubMed ID: 33204716
[TBL] [Abstract] [Full Text] [Related]
[Next]
